You are here

  • Home
  • Archive
  • Volume 2016, Issue
  • Glucocorticoids did not reverse type 1 diabetes mellitus secondary to pembrolizumab in a patient with metastatic melanoma

Article info

Article menu
Download PDFPDF
CASE REPORT
Glucocorticoids did not reverse type 1 diabetes mellitus secondary to pembrolizumab in a patient with metastatic melanoma

Authors

  1. Correspondence to Dr Jasna Aleksova, jasnaaleksova{at}hotmail.com
View Full Text

Citation

Aleksova J, Lau PKH, Soldatos G, et al
Glucocorticoids did not reverse type 1 diabetes mellitus secondary to pembrolizumab in a patient with metastatic melanoma
Case Reports 2016;2016:bcr2016217454.

Publication history

  • Accepted November 9, 2016
  • First published November 23, 2016.
Online issue publication 
August 07, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2016 BMJ Publishing Group Ltd